New cell therapy trial aims to fight Tough-to-Treat blood cancer
NCT ID NCT07476066
Summary
This early-stage study is testing an experimental cell therapy called SYS6055 injection for adults with aggressive B-cell lymphoma that has returned or not responded to standard treatments. The main goals are to find a safe dose and see if the treatment shows early signs of helping control the cancer. Researchers will also track how the body responds to the therapy and look for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.